Market research
001060.KO JW Pharmaceutical Corporation
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 611B
- P/E ratio
- Not available
- Analyst target
- 34000
- Dividend yield
- 2.4%
- Beta
- 1.02
Community
Investor discussion
1 comment
Sign in to join the 001060.KO discussion.
5 years, 5 months ago
JW Pharmaceutical Corporation is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.
From a valuation standpoint, the stock is 86.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
JW Pharmaceutical Corporation's total revenue rose by 27.0% to $145B since the same quarter in the previous year.
Its net income has increased by 70.1% to $-7B since the same quarter in the previous year.
Finally, its free cash flow fell by 65.1% to $9B since the same quarter in the previous year.
Based on the above factors, JW Pharmaceutical Corporation gets an overall score of 4/5.